Skip to main content
Clinical Trials/ISRCTN71797549
ISRCTN71797549
Completed
未知

Feasibility of a randomised controlled trial of a group programme for men who are concerned about their behaviour in relationships with women: a pilot study

niversity of Bristol0 sites51 target enrollmentMay 27, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Bristol
Enrollment
51
Status
Completed
Last Updated
last year

Overview

Brief Summary

2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38678198/ (added 02/05/2024)

Registry
who.int
Start Date
May 27, 2022
End Date
October 31, 2018
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Bristol

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for male participants:
  • 1\. \>21 years of age
  • 2\. Using violence/abuse in their relationship to women partner(s) or ex\-partner(s) and concerned about that behaviour
  • 3\. Ability to read and complete outcome questionnaires
  • Inclusion criteria for partners/ex\-partners:
  • 1\. Female partners or ex\-partners of men using violence/abuse in their relationships
  • 2\. \>18 years
  • 3\. Ability to read and complete outcome questionnaires

Exclusion Criteria

  • Exclusion criteria for male participants:
  • 1\. Men who do not have a female partner or ex\-partner
  • 2\. Court mandated referral to perpetrator programme
  • 3\. Men who are high risk perpetrators of DVA as assessed by the intervention group co\-ordinator
  • 4\. Men who are deemed by the intervention group coordinator not willing to engage with the intervention
  • 5\. Participants who cannot understand the English language sufficiently well to give informed consent and to complete the questionnaires
  • 6\. Participants with a diagnosis of a mental illness that will prevent them from programme
  • engagement, e.g. active psychosis
  • 7\. Participants with current unstable use/misuse of drugs or alcohol
  • Exclusion criteria for partners/ex\-partners:

Outcomes

Primary Outcomes

Not specified

Similar Trials